Clinical Trials

Accrual Status
Limit to SWOG Trials

1040 Results

Closed
Phase
Accrual
17%
SWOG Clinical Trial Number
SWOG-8820
Closed
Phase
Accrual
100%
Published
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8819

Central Lymphoma Repository Tissue Procurement Protocol

Research Committee(s)
Lymphoma
Molecular Epidemiology
Activated
02-15-1989
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8802

Evaluation of Echinomycin in Renal Cell Carcinoma

Activated
01-15-1989
Closed
07-15-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8754
Closed
Phase
Accrual
87%
Published
SWOG Clinical Trial Number
SWOG-8825

Phase I Trial of Intravenous Bolus Melphalan With GM-CSF

Activated
12-15-1988
Closed
12-01-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8725

Evaluation of Amonafide in Cervical Cancer

Activated
12-01-1988
Closed
12-01-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8835
Closed
Phase
Accrual
65%
Published
SWOG Clinical Trial Number
SWOG-8795 (INT-0094) (EST-1888)
Closed
Phase
Accrual
87%
Published
SWOG Clinical Trial Number
SWOG-8719
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
SWOG-8614
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
SWOG-8609

VM-26 (Teniposide) Single Drug Treatment for Extensive Small Cell Lung Cancer

Research Committee(s)
Lung Cancer
Activated
09-15-1988
Closed
11-15-1990
Closed
Phase
Accrual
17%
SWOG Clinical Trial Number
SWOG-8752
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8741
Closed
Phase
Accrual
77%
Published
Closed
Phase
Accrual
8%
Closed
Phase
Accrual
67%
Published
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8737